Detail Page

  • 150012002893187506009581537530023914PublicAssets/2750Antibodies are among the most promising therapies for certain forms of cancer, but patients must take them intravenously, exposing healthy tissues to the drug and increasing the risk of side effects. A team of biochemists packed the anticancer antibodies into porous silica particles to deliver a heavy dose directly to tumors in mice. Chenghong Lei, Pacific Northwest National Laboratory & Karl Erik Hellstrom, University of WashingtonChenghong Lei, Pacific Northwest National LaboratoryIllustration

    Topic Tags:

    Chemistry, Biochemistry, and Pharmacology

    Antibodies in silica honeycomb

    View EntryAdd to My Images

    Antibodies are among the most promising therapies for certain forms of cancer, but patients must take them intravenously, exposing healthy tissues to the drug and increasing the risk of side effects. A team of biochemists packed the anticancer antibodies into porous silica particles to deliver a heavy dose directly to tumors in mice.

    Source

    Chenghong Lei, Pacific Northwest National Laboratory & Karl Erik Hellstrom, University of Washington

    Credit Line

    Chenghong Lei, Pacific Northwest National Laboratory

    Record Type

    Illustration

    ID

    2750

My Images/Videos